IST:SURGY Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Administrative	196.4	176.48	260.29	126.94	91.98
Other Operating Expenses	-0.9	-0.91	3.98	1.85	-8.46
Total Operating Expenses	195.5	175.57	264.27	128.78	83.53
Operating Income	-195.5	-175.57	-264.27	-128.78	-83.53
Interest Expense	-25.03	-26.57	-1.43	-	-
Interest & Investment Income	5.65	4.45	149.37	-	-
Currency Exchange Gain (Loss)	4.13	1.73	0.47	-2.3	-0.15
Other Non-Operating Income	-315.53	-631.73	-267.96	-47.55	-51.63
EBT Excluding Unusual Items	-526.28	-827.69	-383.82	-178.63	-135.31
Gain (Loss) on Sale of Investments	-97.55	-94.24	230.06	12.76	-
Asset Writedown	560.97	560.97	1,190	1,478	747.19
Pretax Income	-62.85	-360.96	1,036	1,313	611.88
Income Tax Expense	214.97	-1,338	605.97	-	-
Net Income	-277.82	976.65	430.32	1,313	611.88
Net Income to Common	-277.82	976.65	430.32	1,313	611.88
Net Income Growth	-	126.96%	-67.21%	114.51%	-
Basic Shares Outstanding	168	168	168	168	70
Diluted Shares Outstanding	168	168	168	168	70
Shares Change	-	-	-	139.29%	-
EPS (Basic)	-1.66	5.83	2.57	7.84	8.74
EPS (Diluted)	-1.66	5.83	2.57	7.84	8.74
EPS Growth	-	126.96%	-67.21%	-10.36%	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
EBITDA	-193.31	-173.38	-262.08	-128.13	-83.47
D&A For Ebitda	2.19	2.19	2.19	0.65	0.05
EBIT	-195.5	-175.57	-264.27	-128.78	-83.53
Effective Tax Rate	-	-	58.48%	-	-